Used in pharmaceutical research as an intermediate for synthesizing bioactive compounds, particularly those targeting neurological and psychiatric disorders. Shows potential in the development of agents affecting neurotransmitter systems due to its structural similarity to certain neuroactive molecules. Also investigated for its role in enzyme inhibition studies, especially related to monoamine oxidases, which are linked to depression and neurodegenerative diseases. Employed in preclinical studies to evaluate metabolic stability and blood-brain barrier penetration of new drug candidates.